MYOCARDIAL TRIGLYCERIDE AND LV PERFORMANCE ASSESS BY MRS AND MRI
通过 MRS 和 MRI 评估心肌甘油三酯和 LV 性能
基本信息
- 批准号:7606358
- 负责人:
- 金额:$ 0.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2007-09-16
- 项目状态:已结题
- 来源:
- 关键词:AdipocytesAdipose tissueBasic ScienceBlood CirculationCardiacCardiomyopathiesCell DeathClinicalComputer Retrieval of Information on Scientific Projects DatabaseConditionDilated CardiomyopathyDirect Lytic FactorsDyslipidemiasFailureFatty acid glycerol estersFundingGrantHeart DiseasesHeart RateHumanHypertensionIndividualInstitutionLaboratoriesLeftLeft Ventricular RemodelingLiverMorbid ObesityMyocardialMyocardial InfarctionMyocardiumNon-Insulin-Dependent Diabetes MellitusNumbersObesityOrganPancreasPerformanceRegulationResearchResearch PersonnelResourcesRiskRisk FactorsScoreSignal TransductionSkeletal MuscleSourceStroke VolumeStructure of beta Cell of isletSyndromeThinkingTissuesTriglyceridesUnited States National Institutes of HealthVentricularconcepthemodynamicsnonalcoholic steatohepatitis
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Traditionally, obesity is considered an indirect cause of heart disease. Obese individuals typically present with a number of traditional Framingham risk factors, (hypertension, dyslipidemia, and type 2 diabetes) predisposing them to myocardial infarction and ischemic cardiomyopathy. In addition to an elevated Framingham risk score, the hemodynamic hallmark of obesity is a hyperdynamic circulation (increased heart rate and stroke volume). It is thought to be a compensatory adaptation to increased adipose mass at the expense of eccentric left ventricular remodeling. In extreme obesity hyperdynamic circulation progresses to non-ischemic dilated cardiomyopathy.
In contrast to these rather traditional concepts, an emerging body of basic research revisits a hypothesis that fat is a direct cardiotoxin. Under healthy conditions, most trigylceride is stored in adipocytes while the amount of triglyceride stored in non-adipocyte tissues (such as the pancreas, the liver, skeletal muscle, and the myocardium) is minimal and very tightly regulated. When this regulation is disrupted, cytosolic triglyceride accumulates excessively in these organs ("steatosis") and has been implicated in activating adverse signaling cascades culminating in irreversible cell death ("lipotoxicity"), leading to several well-recognized clinical syndromes. These include non-alcoholic steatohepatitis (NASH), pancreatic beta-cell failure in type 2 diabetes, and dilated cardiomyopathy.
Initial studies in our laboratory revealed that human obesity and type 2 diabetes are characterized by elevated myocardial triglyceride levels; however, the relationship between myocardial triglyceride levels and cardiac performance remains unclear. The primary aim of this proposal is therefore to determine the influence of myocardial triglyceride content on left ventricular performance in humans.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
传统上,肥胖被认为是心脏病的间接原因。 肥胖个体通常存在许多传统的易患心肌梗死和缺血性心肌病的危险因素(高血压、血脂异常和2型糖尿病)。除了Fracture风险评分升高外,肥胖的血流动力学标志是高动力循环(心率和每搏输出量增加)。这被认为是以牺牲偏心性左心室重构为代价对脂肪量增加的代偿性适应。 在极度肥胖症中,高动力循环发展为非缺血性扩张型心肌病。
与这些相当传统的概念相反,一个新兴的基础研究机构重新审视了一个假设,即脂肪是一种直接的心脏毒素。 在健康条件下,大多数甘油三酸酯储存在脂肪细胞中,而储存在非脂肪细胞组织(如胰腺、肝脏、骨骼肌和心肌)中的甘油三酸酯的量是最小的,并且受到非常严格的调节。 当这种调节被破坏时,胞质甘油三酯在这些器官中过度积累(“脂肪变性”),并参与激活不良信号级联,最终导致不可逆的细胞死亡(“脂毒性”),导致几种公认的临床综合征。 这些包括非酒精性脂肪性肝炎(NASH),2型糖尿病中的胰腺β细胞衰竭和扩张型心肌病。
我们实验室的初步研究表明,人类肥胖和2型糖尿病的特征是心肌甘油三酯水平升高;然而,心肌甘油三酯水平和心脏性能之间的关系尚不清楚。 因此,本提案的主要目的是确定心肌甘油三酯含量对人类左心室性能的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LIDIA S SZCZEPANIAK其他文献
LIDIA S SZCZEPANIAK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LIDIA S SZCZEPANIAK', 18)}}的其他基金
Ethnic Differences in Mechanisms of Pancreatic Beta Cell Failure
胰腺β细胞衰竭机制的种族差异
- 批准号:
8055523 - 财政年份:2009
- 资助金额:
$ 0.23万 - 项目类别:
Ethnic Differences in Mechanisms of Pancreatic Beta Cell Failure
胰腺β细胞衰竭机制的种族差异
- 批准号:
7653976 - 财政年份:2009
- 资助金额:
$ 0.23万 - 项目类别:
Ethnic Differences in Mechanisms of Pancreatic Beta Cell Failure
胰腺β细胞衰竭机制的种族差异
- 批准号:
7989276 - 财政年份:2009
- 资助金额:
$ 0.23万 - 项目类别:
Ethnic Differences in Mechanisms of Pancreatic Beta Cell Failure
胰腺β细胞衰竭机制的种族差异
- 批准号:
7841868 - 财政年份:2009
- 资助金额:
$ 0.23万 - 项目类别:
INSULIN RESISTANCE AND INTRAMYOCELLULAR LIPID CONTENT IN GLUCOSE INTOLERANCE
葡萄糖不耐症中的胰岛素抵抗和肌细胞内脂质含量
- 批准号:
7606314 - 财政年份:2007
- 资助金额:
$ 0.23万 - 项目类别:
INSULIN RESISTANCE AND INTRAMYOCELLULAR LIPID CONTENT IN GLUCOSE INTOLERANCE
葡萄糖不耐症中的胰岛素抵抗和肌细胞内脂质含量
- 批准号:
7377605 - 财政年份:2006
- 资助金额:
$ 0.23万 - 项目类别:
EVALUATION OF MYOCARDIAL LIPIDS BY LOCALIZED PROTON MRS
通过局部质子 MRS 评估心肌脂质
- 批准号:
7206018 - 财政年份:2005
- 资助金额:
$ 0.23万 - 项目类别:
INSULIN RESISTANCE AND INTRAMYOCELLULAR LIPID CONTENT IN GLUCOSE INTOLERANCE
葡萄糖不耐症中的胰岛素抵抗和肌细胞内脂质含量
- 批准号:
7206004 - 财政年份:2005
- 资助金额:
$ 0.23万 - 项目类别:
Evaluation of Myocardial Lipids by Localized Proton MRS
局部质子 MRS 评估心肌脂质
- 批准号:
6975085 - 财政年份:2004
- 资助金额:
$ 0.23万 - 项目类别:
相似海外基金
Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
- 批准号:
MR/Y013891/1 - 财政年份:2024
- 资助金额:
$ 0.23万 - 项目类别:
Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
- 批准号:
BB/Y006542/1 - 财政年份:2024
- 资助金额:
$ 0.23万 - 项目类别:
Research Grant
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
- 批准号:
479570 - 财政年份:2023
- 资助金额:
$ 0.23万 - 项目类别:
Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
- 批准号:
488898 - 财政年份:2023
- 资助金额:
$ 0.23万 - 项目类别:
Operating Grants
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
- 批准号:
23H03323 - 财政年份:2023
- 资助金额:
$ 0.23万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
- 批准号:
23K08293 - 财政年份:2023
- 资助金额:
$ 0.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
- 批准号:
23K19922 - 财政年份:2023
- 资助金额:
$ 0.23万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV
HIV 感染者的脂肪组织 T 细胞极化和代谢健康
- 批准号:
10619176 - 财政年份:2023
- 资助金额:
$ 0.23万 - 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
- 批准号:
10604611 - 财政年份:2023
- 资助金额:
$ 0.23万 - 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 0.23万 - 项目类别: